Kingsview Wealth Management LLC Has $88,000 Stock Holdings in Haleon plc (NYSE:HLN)

Kingsview Wealth Management LLC decreased its holdings in Haleon plc (NYSE:HLN) by 40.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,696 shares of the company’s stock after selling 7,272 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Haleon were worth $88,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in HLN. FMR LLC raised its stake in shares of Haleon by 22.2% in the 3rd quarter. FMR LLC now owns 53,951,936 shares of the company’s stock valued at $449,420,000 after buying an additional 9,812,040 shares in the last quarter. Wellington Management Group LLP acquired a new stake in shares of Haleon during the 3rd quarter worth about $42,640,000. Envestnet Asset Management Inc. increased its position in shares of Haleon by 121.2% during the 3rd quarter. Envestnet Asset Management Inc. now owns 5,931,187 shares of the company’s stock worth $49,407,000 after purchasing an additional 3,249,517 shares in the last quarter. Cambiar Investors LLC acquired a new stake in shares of Haleon during the 4th quarter worth about $15,225,000. Finally, Kayne Anderson Rudnick Investment Management LLC increased its position in shares of Haleon by 6,593.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,692,937 shares of the company’s stock worth $14,102,000 after purchasing an additional 1,667,643 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Argus reiterated a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC assumed coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a “buy” rating for the company. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy”.

Haleon Stock Down 0.4 %

Shares of NYSE:HLN opened at $8.47 on Friday. Haleon plc has a 12 month low of $7.70 and a 12 month high of $8.96. The company’s 50-day moving average price is $8.32 and its two-hundred day moving average price is $8.32. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The firm has a market cap of $38.68 billion, a P/E ratio of 28.23, a P/E/G ratio of 2.26 and a beta of 0.28.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The firm had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. As a group, research analysts forecast that Haleon plc will post 0.46 EPS for the current fiscal year.

Haleon Announces Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, May 16th. Stockholders of record on Friday, March 15th were paid a $0.1064 dividend. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend was Thursday, March 14th. Haleon’s dividend payout ratio (DPR) is presently 70.00%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.